Insulin Aspart
NDC 70518-3865, insulin aspart, injection, solution, from REMEDYREPACK INC..
- Product NDC
- 70518-3865
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA020986
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3865 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN ASPART100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-3865-0 | 70518386500 | 5 SYRINGE, PLASTIC in 1 CARTON (70518-3865-0) / 3 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b3d77cb0-cd47-441f-8f54-5329c655da9c
Use it
Look up 70518-3865 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3865 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-3865. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.